Human Gastric Carcinogenesis: A Multistep and Multifactorial Process- First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention

Cancer Research

Volumn 52, Issue 24, 1992, Pages 6735-6740

  Correa, Pelayo ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA CAROTENE; CARCINOGEN; CAROTENOID; NITROSO DERIVATIVE; PEPSINOGEN I; PEPSINOGEN II; SODIUM CHLORIDE; TUMOR MARKER;

ATROPHIC GASTRITIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHRONIC GASTRITIS; CONFERENCE PAPER; EPITHELIUM DYSPLASIA; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PRIORITY JOURNAL; SALT INTAKE; STOMACH CARCINOMA;

ASCORBIC ACID; CARCINOGENS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMAN; SODIUM, DIETARY; STOMACH NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027065034     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Kurihara, M., Aoki, K., and Hisatnichi, S. Cancer mortality statistics in the world 1950-1985. Nagoya, Japan: The University of Nagoya Press, 1989.
2. Parkin, M. D., Stjernsward, J., and Muir, C. Estimates of the worldwide frequency of twelve major cancers. Int. J. Cancer, 41: 184-197, 1988.
3. Muir, C., Waterhouse, J., Mack, T., Powell, J., and Whelan, S. Cancer Incidence in Five Continents, Vol. 5. Scientific Publication 88.1987. Lyon, France: International Agency for Research on Cancer, 1987.
4. Cady, B., Ross, R., and Silverman, M. Gastric adenocarcinoma. A disease in transition. Arch. Surg., 124: 303-308, 1989.
5. Blot, W. J., Devesa, S., Kneller, R., and Fraumeni, J. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 265: 1287-1289, 1991.
6. Munoz, N., and Connelly, R. Time trends in intestinal and diffuse types of gastric carcinoma. Int. J. Cancer, 8: 158-164, 1971.
7. Correa, P., Haenszel, W., Cuello, C., et al. Gastric precancerous process in a high risk population: cross sectional studies. Cancer Res., 50: 4731-4736, 1990.
8. Correa, P., Haenszel, W., Cuello, C., et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res., 50: 4737-4740, 1990.
9. Correa, P. A human model of Human Gastric Carcinogenesis. Cancer Res., 48: 3854-3860, 1988.
10. Correa, P. The new era of cancer epidemiology. Cancer Epidemiol. Biomarkers & Prev., 7:5-11, 1991.
11. Silva, S., and Filipe, M. I. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. Hum. Pathol., 17: 988-995, 1986.
12. Torrado, J., Blasco, E., Gutierrez, A., et al. Lewis system alterations in Human Gastric Carcinogenesis. Cancer (Phila.), 66: 1769-1774, 1990.
13. Torrado, J., Correa, P., Ruiz, B., Zavala, D., and Bara, J. Prospective study of Lewis antigens in the gastric precancerous process. Cancer Epidemiol. Biomarkers & Prev., 1: 199-205, 1992.
14. Burr, M. L., Samloff, I. M., Bates, C. J., and Holliday, R. M. Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates. Br. J. Cancer, 56: 163-167, 1987.
15. Palli, D., Dacarli, A., Cipriani, F., et al. Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk. Cancer Epidemiol. Biomarkers & Prev., 1: 45-50, 1991.
16. Miki, K., Ichinose, M., Kawamura, N., Matsuchima, M., et al. The significance of low pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn. J. Cancer Res., 80: 111-114, 1984.
17. Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., and Rolter, J. I. Relationship among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology, 83: 204-209, 1982.
18. Correa, P., Haenszel., W., Cuello, C., Arder, M., and Tannenbaum, S. R. A model for gastric cancer epidemiology. Lancet, 2: 58-60, 1975.
19. Blaser, M. J. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-mAuciA inflammation. Gastroenterology, 102: 1720-1727, 1992.
20. Parsonnett, J., Friedman, G., Vandersteen, D., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325: 1127-1131, 1991.
21. Sierra, R., Muiioz, N., Peiia, S., et al. Antibodies to Helicobacter pylori and pepsinogen levels in children in Costa Rica. Cancer Epidemiol. Biomarkers & Prev., 1: 449-454, 1992.
22. Forman, D., Newell, D. G., Forllerton, F., et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J., 302: 1302-1305, 1991.
23. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I., and Blaser, M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med., 325: 1132-1136, 1991.
24. Talley, N. J., Zinsmeister, A. R., Weaver, A., et al. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst., 83:1734-1739, 1991.
25. orrea, P. Is gastric carcinoma an infectious disease? N. Engl. J. Med., 325: 1170-1171, 1991.
26. Correa, P., and Ruiz, B. Helicobacter pylori and gastric cancer. In: B. J. Rathbone and R.V. Heatley (eds.), Helicobacter pylori and Gastrointestinal Disease, Ed. 2, in press, 1992.
27. Sato, T., Fukuyama, S., Susuki, T., and Takanagi, J. The relationship between gastric cancer mortality and salted food intake in several places in Japan. Bull. Inst. Public Health, 8: 187-198, 1959.
28. Joossens, J. V., and Geboers, J. Nutrition and gastric cancer. Nutr. Cancer, 2: 250-261, 1981.
29. Tatematsu, M., Takahashi, M., Fukushima, S., Hananouchi, M., and Shirai, T. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitroso guanidine or 4-nitroquinoline-l-oxide. J. Natl. Cancer Inst., 55: 101-106, 1975.
30. Charnley, G., and Tannenbaum, S. R. Flow cytometric analysis of the effect of sodium chloride on gastric cancer risk in the rat. Cancer Res., 45: 5608-5616, 1985.
31. Ames, B. N., and Gold, L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science (Washington DC), 249: 970-971, 1990.
32. Kodama, M., Kodama, T., Susuki, H., and Kondo, K. Effect of rice and salty rice diet on the structure of mouse stomach. Nutr. Cancer, 6:135-147,1984.
33. Rojas-Campos, N., Sigaran, N., Bravo, A. C., and Correa, P. Salt enhances the mutagenicity of nitrosated black beans. Nutr. Cancer, 14: 1-3, 1990.
34. You, W. C., Blot, W. J., Chang, Y. S., et al. Allium vegetables and reduced risk of stomach cancer. J. Natl. Cancer Inst., 81: 162-164, 1989.
35. Block, G. Vitamin C and cancer prevention. The epidemiologic evidence. Am. J. Clin. Nutr., 53: 2705-2825, 1991.
36. Caygill, C. P. J. UK subgroup of ECP-EURONUT-IM study group. Plasma vitamin concentration in patients with intestinal metaplasia and in controls. Eur. J. Cancer Prev., 1: 177-186, 1992.
37. Sobala, G. M., Schorah, C. J., Sanderson, M., et al. Ascorbic acid in the human stomach. Gastroenterology, 97: 357-363, 1989.
38. Haenszel, W., Correa, P., Lopez, A., Cuello, C., Zarama, G., Zavala, D., and Fontham, E. Serum micronutrient levels in relation to gastric pathology. Int. J. Cancer, 36: 43-48, 1985.
39. Santamaria, C., Bianci, A., Ravetto, C., Arnaboldi, A., Santogati, G., and Andreoni, L. Prevention of gastric cancer induced by MNNG in rats fed supplemental carotenoids. J. Nutr. Growth Cancer, 175-181, 1987.
40. Bertram, J., Hossain, M. Z., Pung, A., et al. Development of in vitro system for chemoprevention research. Prev. Med., 18: 569-573, 1984.
41. Arroyo, P. L., Hatch-Pigott, V., Mower, H. F., and Cooney, R. V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res., 281: 193-202, 1992.
42. Tatematsu, M., Takahashi, M., and Fukushima, S. Effects in rats of sodium chlorida on experimental gastric cancers induced by N-methyl-N-nitro-7V-nitrosoguanidine and 4-nitroquinoline-l-oxide. J. Natl. Cancer Inst., 55: 101-106, 1975.
43. Fontham, E., Zavala, D., Correa, P., Rodriguez, E., Hunter, F., Haenszel, W., and Tannenbaum, S. R. Diet and chronic atrophic gastritis: a case-control study. J. Natl. Cancer Inst., 76: 621-627, 1986.
44. Kneller, R., You, W. C., Liu, D., et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J. Natl. Cancer Inst., 84: 1261-1266, 1992.
45. Yang, D., Tannenbaum, S. R., Buch, C., and Lee, G. C. M. 4-Chloro-6-methoxyindole is the precursor of a potent mutagen that forms during nitrosation of fava beans (Vida faba). Carcinogenesis (Lond.), 5: 1219-1224, 1984.
46. Tiednik, H. G. M., De Haan, L. H. J., Jongen, W. M. F., and Koeman, J. H. In vitro testing and the carcinogenic potential of several nitrosated indole compounds. Cell. Biol. Toxicol., 7: 371-386., 1991.
47. Wakabayashi, K., Nagao, K., Ochiai, M., et al. A mutagen precursor in Chinese cabbage, indole-3-acetonitrite, which becomes mutagenic on nitrite treatment. Mutat. Res., 143: 17-21, 1985.
48. Sierra, R., Oshima, H., Munoz, N., et al. Exposure to N-nitrosamines and other risk factors for gastric cancer in Costa Rican Children. In: I. K. O'Neill, J. Chen, and H. Bartsch (eds.), Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins, pp. 162-167. Lyon, France: International Agency for Research on Cancer, 1991.
49. Stillwell, W. G., Glogowski, S., Xu, H. X., et al. Urinary excretion of nitrate. N-nitrosoproline, 3-methyladenine and 7-methylguanine in a Colombian population at high risk for gastric cancer. Cancer Res., 51: 190-194, 1991.
50. Calmels, S., Bereziat, J. C., Oshima, H., and Bartsch, H. Bacterial formation of N-nitrosocompounds in rats after omeprazole-induced achlorhydria. In: I. K. O'Neill, J. Chen, and H. Bartsch (eds.). Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins. Scientific Publication No. 105, pp. 187-191. Lyon, France: International Agency for Research on Cancer, 1991.
51. Stemmermann, G. N., Mower, H., Price, S., et al. Mutagens in extracts of gastric mucosa. In: R. Bruc, P. Correa, M. Lipkin, S. R. Tannenbaum, and T. Wilkins (eds.). Gastrointestinal Cancer, Endogenous Factors. Banbury Rep., 7: 175-183, 1981.
52. Leaf, C. D., Wishnok, J. S., and Tannenbaum, S. R. Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine stimulated by E. coli lipopolysaccharide in the rat. Carcinogenesis (Lond.), 12: 537-539, 1991.
53. Nguyen, T., Brunson, D., Crespi, J. L., et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad Sci. USA, 89: 3030-3039, 1992.
54. Soman, N. R., Correa, P., Ruiz, B. A., and Wogan, G. N. The TRP-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc. Natl. Acad Sci. USA, 88: 4892-4896, 1991.
55. Kato, K., and Nakazato, H. Gastric cancer: survival rates of “early gastric cancer. Nagoya J. Med. Sci., 38: 35-42, 1975.
56. Oshima, A., Hirata, N., Ubukata, T., et al. Evaluation of a mass screening program for stomach cancer with a case-control design. Int. J. Cancer, 38: 829-833, 1986.